DexCom (DXCM) revenue

Revenue · fiscal 2025
$4.66B

DexCom (DXCM) reported revenue of $4.66B in fiscal 2025 (the year ended December 31, 2025). That is 15.6% higher than the $4.03B of fiscal 2024. Figures as of 19 Nov 2026, 07:08 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$4.66B
Change on fiscal 2024
+15.6%
Growth, 5 years
+19.3% a year
Growth, 10 years
+27.8% a year
Highest on record
$4.66Bfiscal 2025
Lowest on record
$29.69Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

DexCom revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 19.3% a year; over ten years the rate was 27.8% a year. Across the 17 fiscal years on record (2009–2025), the highest was $4.66B in fiscal 2025 and the lowest $29.69M in fiscal 2009.

History · 17 fiscal years

Revenue by fiscal year

DexCom revenue, year by year

DexCom (DXCM) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$4.66B 15.6% up
2024$4.03B 11.3% up
2023$3.62B 24.5% up
2022$2.91B 18.8% up
2021$2.45B 27.1% up
2020$1.93B 30.5% up
2019$1.48B 43.1% up
2018$1.03B 43.6% up
2017$718.50M 25.3% up
2016$573.30M 42.6% up
2015$402.00M 55.1% up
2014$259.20M 62.0% up
2013$160.00M 60.2% up
2012$99.90M 30.9% up
2011$76.30M 57.0% up
2010$48.60M 63.7% up
2009$29.69M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of DexCom and comparable companies
CompanyRevenueFiscal year
Labcorp Holdings LH$13.95B2025
DexCom DXCM$4.66B2025
Koninklijke Philips PHG€17.83B2025
Roivant Sciences ROIV$8.26M2026
West Pharmaceutical Services WST$3.07B2025
Quest Diagnostics DGX$11.04B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DXCM

DexCom, figure by figure

DexCom (DXCM) overview: price, valuation and scorecardAll health care companies by market value

DexCom revenue: questions and answers

What is DexCom's revenue?

DexCom (DXCM) reported revenue of $4.66B in fiscal 2025 (the year ended December 31, 2025). That is 15.6% higher than the $4.03B of fiscal 2024.

What is the growth rate of DexCom's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 19.3% a year; over ten years the rate was 27.8% a year.

What are the highest and lowest revenue figures on record for DexCom?

Across the 17 fiscal years on record (2009–2025), the highest was $4.66B in fiscal 2025 and the lowest $29.69M in fiscal 2009.

How is DexCom's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For DexCom it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “DexCom (DXCM) revenue”, data as of 19 November 2026. https://funkfolio.com/stock/DXCM/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.